Drug Type Antibody |
Synonyms- |
Target |
Mechanism CLEC-2 inhibitors(C-type lectin domain family 1 member B inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Thrombosis | Preclinical | DE | 09 Jul 2022 |